Results 61 to 70 of about 9,578 (173)

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia [PDF]

, 2009
In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemken, Ethiopia, a highland region where only few cases had been reported before. We analyzed records of VL patients treated from May 25, 2005 to December 13, 2007 by the
Alvar, J, Aparicio, P, Argaw, D, Bashaye, S, Bern, C, Bernal, O, Flevaud, L, Herrero, M, Lima, M A, Mulugeta, A, Orfanos, G, Palma, P P, Parreño, F, Pedraza, J, Rubens, D   +14 more
core   +1 more source

Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996–2016: a retrospective study of clinical characteristics, treatments and outcomes

BMC Infectious Diseases, 2018
Background Leishmaniasis is a neglected and poorly reported parasitic infection transmitted by sand flies in tropical and subtropical regions. Knowledge about leishmaniasis has become important in non-endemic countries due to increased migration and ...
Hedvig Glans, Leif Dotevall, Sara Karlsson Söbirk, Anna Färnert, Maria Bradley   +4 more
doaj   +1 more source

Treatment of cutaneous leishmaniasis among travellers [PDF]

, 2017
Leishmaniasis is endemic in 88 countries on five continents. There are 1-1.5 million cases of cutaneous leishmaniasis reported yearly worldwide. There has been a sharp increase in recorded cases over the last 10 years. Based on geographical distribution,
Beck, B., Blum, J., Desjeux, P., Hatz, C., Schwartz, E.   +4 more
core  

Engineering synergistically active and bioavailable cost-effective medicines for neglected tropical diseases; the role of excipients [PDF]

, 2017
Leishmaniasis is a neglected tropical disease responsible for the ninth largest disease burden in the world threatening 350 million people mostly in developing countries.
Dea Ayuela, Maria Auxiliadora, Lalatsa, Aikaterini, Serrano Lopez, Dolores Remedios   +2 more
core   +2 more sources

Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy [PDF]

, 2017
Guidelines recommend wound care and/or local therapy as first-line treatment for cutaneous leishmaniasis. An analysis of a referral treatment program in 135 travelers showed that this approach was feasible in 62% of patients, with positive outcome in 83%
Abergel, H., Alcaraz, I., Amoric, J. C., Ancelle, T., Baccard, M., Barthelme, D., Begon, E., Belon, M., Belot, G., Beneton-Benhard, N., Bezier, M., Bodak, N., Bougnoux, M. E., Bourgeois, A., Bourrat, E., Broissin, M., Buffet, P. A., Busquet, P., Caby, F., Canestri, A., Carpentier, O., Carre, D., Caumes, E., Celerier, P., Clabaut, A., Colin De Verdiere, N., Consigny, P. H., Cordoliani, F., Cuchet, E., Dallot, A., Datry, A., Dellestable, P., Dumortier, C., Dupin, N., Dupuis De Fonclare, A. L., Durupt, F., El Samad, Y., Foulet, F., Galezowsky, M. F., Gangneux, J. P., Gener, G., Gounod, N., Grogl, M., Grossetête, G., Guillemot, F., Hadj Rabia, S., Hamel, D., Herve, A., Hillion, B., Hochedez, P., Hope Rapp, E., Janier, M., Jouan, M., Jouy, L., Juillard, C., Karam, S., Kendjo, E., Kieffer, C., Lachaud, L., Laffitte, E., Le Duc, D., Lesens, O., Levy, A., Marty, P., Maubon, D., Maus, E., Mazier, D., Mechai, F., Menot, E., Meunier, L., Moisson, Y. F., Moraillon, I., Morizot, G., Mouly, F., Mouri, O., Ortoli, J. C., Paugam, A., Pelletier-Cunat, S., Perrin, P., Petit, A., Pomares, C., Pérignon, A., Ranque, B., Ravel, C., Rebauder, S., Regner, S., Roch, N., Rogeaux, O., Rozembaum, F., Salle, V., Schneider, P., Strady, C., Tamarin, J. M., Thellier, M., Timsit, F., Verdon, R., Vray, M., Wolter-Desfosses, M.   +97 more
core  

Cutaneous Leishmaniasis (CL) in Saudi Arabia: Current Status [PDF]

, 2014
Cutaneous leishmaniasis (CL) is a major tropical infection of public health importance. It is caused by a group of protozoan intracellular parasites. Several factors contribute to the prevalence and transmission of CL.
Zakai, H. A. (Haytham)
core   +1 more source

An update on Leishmania martiniquensis infections: Transmission, clinical characteristics, and treatment

Parasite Epidemiology and Control
Leishmaniasis, caused by intracellular protozoa of the Leishmania genus, continues to be a global health issue, with approximately 700,000 to 1 million new cases occur annually worldwide.
Somayyeh Ahmadi, Maryam Hataminejad, Bahman Rahimi Esboei, Seyed Abdollah Hosseini, Mahdi Fakhar   +4 more
doaj   +1 more source

Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil

Revista da Sociedade Brasileira de Medicina Tropical, 2019
INTRODUCTION: American tegumentary leishmaniasis (ATL) and leprosy share common areas of prevalence, but reports of coinfection are scarce. METHODS: We report a series of 9 ATL-leprosy cases and discuss the association.
Sebastian Vernal, Roberto Bueno-Filho, Ciro Martins Gomes, Ana Maria Roselino   +3 more
doaj   +1 more source

First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran

Journal of Infection in Developing Countries, 2013
Mucocutaneous leishmaniasis, which mostly occurs in the New World, is mainly associated with Leishmania braziliensis and to a lesser degree L. panamensis and L. amazonensis infections.
Abdolvahab Alborzi, Gholam R Pouladfar, Abdolkarim Ghadimi Moghadam, Armin Attar, Nima Drakhshan, Mohsen Khosravi Maharlooei, Mohsen Kalantari   +6 more
doaj   +1 more source

Application of magnetically induced hyperthermia on the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections

, 2012
Magnetic hyperthermia is currently an EU-approved clinical therapy against tumor cells that uses magnetic nanoparticles under a time varying magnetic field (TVMF).
Asín, L., Goya, G. F., Grazú, V., Ibarra, M. R., Marquina, C., Moros, M., Silber, A. M., Torres, T. E.   +7 more
core   +1 more source